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Rhinosinusitis is a very common disease worldwide and speciﬁcally in the US population. It is a common disease in children but
maybeunderdiagnosed.Severalreasonsmayaccounttothediseasebeingmissedinchildren.Thesymptomsinchildrenarelimited
and can be very similar to the common cold or allergic symptoms. Cough and nasal discharge may be the only symptoms present
in children. A high index of suspicion is necessary to make the diagnosis of rhinosinusitis in these children. The majority of those
children are treated medically. Only a few number will require surgical intervention when medical treatment fails. Complications
of rhinosinusitis, even though rare, can carry a high morbidity and mortality rate.
1.Introduction
Rhinosinusitis (RS) is a common disease in children that is
sometimes overlooked. Children average 6–8 upper respira-
tory viral illness with 0.5–5% of these progressing to acute
rhinosinusitis(ARS).Anundeﬁnednumberofthesechildren
will progress to have chronic rhinosinusitis (CRS) [1]. The
disease has great impact on the health care system and the
national economy as a whole [2].
The clinical symptoms of ARS in children include nasal
stuﬃness, colored nasal discharge, and cough with resultant
sleep disturbance. Facial pain/headache can be present in
older children. ARS is deﬁned as symptoms lasting up to 4
weeks, subacute is when symptoms are between 4 weeks and
12 weeks, and CRS is when symptoms have been present for
more than 12 weeks [3].
Rhinosinusitis is deﬁned as a symptomatic inﬂammatory
condition of mucosa of the nasal cavity and paranasal si-
nuses, the ﬂuids within these sinuses, and/or the underlying
bone [4]. The term “sinusitis” has been supplanted by “rhi-
nosinusitis” due to evidence that the nasal mucosa is almost
universally involved in the disease process [5].
2.Etiology andPathogenesis
The etiology of CRS is a subject of much debate and ongoing
research. The current hypothesis is that of a multifactorial
pathogenesis. The paranasal sinuses are a group of paired,
aerated cavities that drain into the nasal cavity via the sinus
ostia. Several ostia drain in the middle meatus leading to
the “osteomeatal complex” (OMC) as the focus of pathol-
ogy [6]. Though the true anatomic role of the paranasal
sinuses is uncertain, their ability to clear normal mucous
secretions depends on three major factors: ostial patency,
ciliary function, and mucous consistency [4, 7]. Any variety
of inciting factors may irritate the sinus mucosa leading
to inﬂammation, edema, bacterial proliferation, outﬂow
obstruction, and mucociliary dysfunction.
The association between CRS and allergic conditions,
speciﬁcally rhinitis, has been well studied. Studies have
shown that patients with persistent or seasonal allergic
rhinitis had more signiﬁcant radiographic ﬁndings of sinus
disease [8, 9]. Further, CRS patients with concomitant
allergic rhinitis have a signiﬁcantly decreased rate of long-
term success following surgical treatment [10].
Microbes have a controversial role in CRS. Though
viral infections are known to precede episodes of viral
rhinosinusitis [11], viral infections are not usually targeted
as a part of CRS treatment. The use of antibacterial
agents, however, has remained a ﬁrst-line treatment for
many practitioners despite the questionable role of bacteria.
The paranasal sinuses, normally considered sterile, house a
characteristic set of bacteria in CRS. A recent study showed
that greater than half of CRS patients studied produced2 International Journal of Pediatrics
polymicrobial ﬂora. The most common pathogens were
those found in ARS. Staphylococcus aureus and coagulase-
negative staphylococci were noted in those cultures from
children with chronic disease. Anaerobes have been shown
to be present in higher percentage in children with CRS
[12]. The literature is replete with studies showing favorable
patient response to treatment with antibiotics targeting these
species, suggesting that there is some role for bacteria in CRS
etiology [13].
The role of inﬂammatory mediators in the pathogenesis
of CRS in children is still vague. In adults, emphasis is made
on inﬂammatory response to the presence of bacteria rather
than the action of microbes themselves. The ﬁnding of a
sinusmucosalinﬁltrateofeosinophils,plasmacells,andlym-
phocytes suggests a process of “bacterial allergy.” In reality,
thereislikelyaspectrumofillnessrangingfromaninfectious
etiology to a purely noninfectious inﬂammation [14].
Systemic factors can predispose to the development of
CRS. Cystic ﬁbrosis patients develop chronic mucosal in-
ﬂammation and nasal polyps causing mechanical obstruc-
tion of sinus ostia [15]. Primary ciliary dyskinesia, though
uncommon, is an example of CRS caused by a defect in
a speciﬁc element of mucociliary clearance [16]. When
clinically suspected, testing for the presence of allergy or
any of the other above conditions will assist in tailoring a
treatment regimen.
3. CaseStudy
3.1. Chief Complaint. A 5-year-old girl presents to her pri-
mary care physician complaining of nasal stuﬃness, colored
nasal discharge, and cough for the past few weeks.
3.2. History. The patient has been stuﬀy and has been having
a cough mainly at night that is keeping parents and child
awake. This has been going on for some time over the past
year. She does get treated with antibiotics; she seems to get
better but then it starts again. Parents have been frustrated
becauseofthat.Shewasdiagnosedwithasthmaandhasbeen
oninhalersandmedicationsbutwithfrequentexacerbations.
She was tested for allergies, and she does not seem to have
any, despite that she has been on nasal steroid sprays as well
as oral antihistamines over the past several months. This
current episode started a couple of weeks ago and has not
resolved despite the oral antihistamines, nasal steroid sprays,
and cold medicine.
Her past medical history is negative. The child snores
when sick, but no history of sore throats or ear infections.
There is also no prior history of surgery. Grandparents do
smoke but not near her.
3.3. Physical Examination. The patient is a healthy-appear-
ing girl, very cooperative with normal vital signs. Heart
and lung sounds are normal. Examination of the head
and neck reveals a nasal septum deviated to the right.
Anterior rhinoscopy shows bilateral hypertrophy of the
inferior turbinates with mucopurulent discharge. Ears are
clear with mobile tympanic membranes. Oral cavity is clear
with no enlargement of the tonsils. No submucous cleft is
noted.
4.Diagnosis
CRS in children is a clinical diagnosis. It is based on clinical
presentation as well as duration of symptoms. In the ﬁrst 7–
10 days it is usually a viral one except if symptoms worsen
and a complication develops. If symptoms persist and are
not improving by 10 days, then acute rhinosinusitis needs to
be entertained [17]. CRS is when symptoms persist beyond
12 weeks. Sometimes acute exacerbations of these symptoms
can occur.Allergic rhinitis can present with a similar clinical
picture and must be distinguished based on timing of
s y m p t o m s ,a sw e l la sp r e s e n c eo ra b s e n c eo fp u r u l e n c e .
The physical examination of a patient suspected to have
CRS involves direct visualization of the nasal cavity and as-
sociated structures. Anterior rhinoscopy with an otoscope is
easy in children and should be a part of the initial evaluation.
Attention is given to the nasal septum, all visible turbinates,
and the presence of colored discharge. Nasal endoscopy in
the older or more cooperative child may be very helpful.
Some authors have reported on the use of laboratory
tests, including sedimentation rate, white blood cell counts,
andC-reactiveproteinlevels,tohelpdiagnoseacutesinusitis.
These tests appear to add little to the predictive value of
clinical ﬁndings in the diagnosis [18].
Imaging studies are not necessary when the probability
of sinusitis is either high or low but may be useful when
the diagnosis is in doubt, based upon a thorough history
and physical examination. Plain sinus radiographs may
demonstrate mucosal thickening, air-ﬂuid levels, and sinus
opaciﬁcation. A CT scan is necessary when a complication
is suspected, in children with polyps, or in those children
who failed medical therapy and are considered for surgery
(Figure 1)[ 1].
5. Treatment
The case presented meets the diagnostic criteria for CRS
based on her complaints of nasal stuﬃness, colored nasal
discharge, and cough with acute exacerbations for greater
than 12 weeks, as well as a ﬁnding of colored discharge on
anterior rhinoscopy.
The goal of treatment in rhinosinusitis is to reduce
the mucosal inﬂammation thus relieving the blockage of
the ostia and impairment of mucociliary ﬂow that is the
hallmark of the disease.
Empiric treatment with a course of orally administered
antibiotics has been a mainstay of treatment. For ARS a 10–
14 days course of oral amoxicillin is ﬁrst line of treatment.
If the patient dose not get better in 48–72 hours, then
antibiotic should be changed to amoxicillin with clavulanic
acid. Three to four weeks of amoxicillin with clavulanic acid
is a ﬁrst-line choice for CRS or those children with acute
exacerbation of CRS because of adequate penetration of the
sinus mucosa and eﬃcacy against S. aureus and anaerobes
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However, in adult cases of treatment failure, culture and
sensitivity from sinus secretions can guide antibiotic choice
[20]. Since this cannot be performed in children in the
oﬃce, performing those cultures in the operating room
can be an option. Obtaining cultures is not the standard
of care for initial therapy, however. There is a lack of
evidence comparing randomized head-to-head eﬃcacy of
the various antibiotic classes or demonstrating a beneﬁt of
multiantibiotic regimens.
Initial medical management also includes a regimen of
topically applied corticosteroids. Fluticasone, beclometha-
sone, budesonide, and mometasone are popular choices.
Topical corticosteroids have been shown to downregulate the
inﬂammatory cytokine proﬁle of sinus mucosa and improve
subjective patient symptoms [21–23]. Though uncommon,
patients should be aware of local side eﬀects of mucosal
drying and bleeding. Often, the choice of agent simply
depends on local practice patterns. Duration of therapy is up
to 3 months, and patient response is unlikely before 2 weeks
of use. Systemic absorption of topical agents is minimal,
but there is evidence that using metered-dose inhalers,
rather than spray bottles, prevents accidental overdose and
subsequent adrenal suppression [21]. Systemic steroids in
burst or taper are generally avoided due to side eﬀects. They
do have a role in patients with signiﬁcant polyposis, as this
may physically prevent the delivery of topical agents to the
site of action. Saline nasal irrigation with a 2-3% solution
hasbeenfoundtobehelpful.Dailyirrigationhasbeenshown
to signiﬁcantly decrease symptoms and improve QOL scores
[24, 25]. Relief is likely due to improved mucous outﬂow and
a decrease in secretions and load of inﬂammatory mediators.
Some clinicians prescribe the use of nasal decongestants
for symptomatic use. These agents, however, should not
be used for longer than 3-4 days because they are rela-
tively short acting and can cause rebound congestion with
chronic use. There is also ongoing research into the use of
antileukotrienes. Although they are theoretically eﬀective in
situationsofeosinophilicinﬂammation,substantialevidence
is lacking [16]. Future directives in medical management
includetheuseofimmunotherapytodecreaseinﬂammation,
especially in patients with recalcitrant disease and those with
concurrent allergic disease.
6. Treatment Failures
In cases of treatment failure, a referral to an otolaryn-
gologist can be helpful for further treatment and possibly
surgical intervention. Other indications for referral include
the presence of severe signs including bleeding, orbital
symptoms, facial swelling, uncertainty regarding diagnosis,
or the presence of nasal polyposis.
Nasal endoscopy in a cooperative child and the older
child in the oﬃce can be very informative. Anatomical ab-
normalities, nasal polyps, and adenoid hypertrophy are
ﬁndings that will help with further management of the child
(Figure 2).
Based on the exam ﬁndings, a CT scan can be obtained.
It is important that the scan is obtained after at least
Figure 1:LateralplainX-rayshowingair-ﬂuidlevelinthemaxillary
sinus.
Figure 2: An endoscopic view using a 2.7mm zero-degree rigid
scope showing enlarged adenoids.
3-weekcourseofantibiotics.Plainﬁlmsofthesinusesarenot
helpful because of low sensitivity and speciﬁcity. MRI does
have a place in the evaluation of complications, soft tissue
involvement, and suspected neoplasia.
After referral for further evaluation, our patient had mu-
copurulence bilaterally. After treatment with 20 days of
antibioticsandtopicalnasalsteroidswithnasalsalinewashes,
a CT scan was obtained, and it showed blockage of her
osteomeatal complex area with mucosal thickening in both
maxillary sinuses (Figure 3).
7.SurgicalManagement
Surgical management for CRS that failed medical therapy
in adults is ESS [26]. In children, however, we have several
surgical options to consider prior to ESS. Most advocate an
adenoidectomy as an initial step in the surgical management
of those children. The success rate however is in the 50–
60% [27, 28] range which is less than the 87% success
rate with ESS [29]. Interestingly, a recent study comparing
bioﬁlm presence of adenoid samples from children with CRS
found an incidence of 95% bioﬁlm present in those samples
compared to only 2% in adenoid samples of children with4 International Journal of Pediatrics
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Figure 3: Coronal CT scan of the sinuses demonstrating signiﬁcant
disease in both ethmoids and maxillary sinuses with blockage of the
OMC.
sleep apnea. This may partially explain the importance of
removing the adenoids in those children with CRS [30].
Otolaryngologists are reluctant to proceed with ESS as a
1st line of treatment because of the fear of facial growth
retardation [31]. Despite the fact that one study showed no
diﬀerence in facial growth 10 years after ESS in children
compared to a comparative group of children who had no
surgery,thatconcernisstillthere[32].Becauseoftheaverage
success rate with adenoidectomy alone, a sinus wash at the
time of adenoidectomy has been advocated. The procedure
will ﬂush the sinuses, and at the same time a culture for
antibiotic guidance would be obtained. Success rate with this
procedure was 88% [33].
After a detailed review of those children who failed
adenoidectomy was reviewed, it was noted that children with
asthma or severe sinus disease as noted by their CT scan
score had the worst outcome. Based on that information,
subsequentstudies have noted that children with asthma and
a more severe disease had a much improved outcome if a
sinus wash or sinus surgery was performed at the time of
adenoidectomy [34].
Functional endoscopic sinus surgery (FESS) is a term
for minimally invasive procedures designed to restore the
natural drainage pathways of the paranasal sinuses [26].
FESS is performed under general anesthesia, typically as a
same-day procedure. The nasal cavity is directly visualized,
and various specialized tools are used to relieve obstructive
lesions of sinus outﬂow including polyps and diseased
mucosa. The aﬀected sinus air cells are opened in a manner
that augments natural mucociliary outﬂow. The procedure is
usually a conservative one in those children [35].
FESS is indicated in patients with CRS who fail medical
therapy or demonstrate complications of disease. Surgical
complications are rare and are usually related to damage
to adjacent structures including the orbital contents and
the skull base. Regular postoperative followup is essential.
Medicalmanagementwithantibioticsandintranasalsteroids
maycontinuepostoperatively,speciﬁcallyifthechildrenhave
allergic rhinitis.
8. Outcomes and Summary
Our patient had an adenoidectomy with a sinus wash of her
maxillary sinuses, since she had severe asthma and severe
disease based on her CT scan. There were no operative com-
plications. Postoperatively she was given culture-directed
oralantibioticsfor14days.At-six-monthfollowup,therewas
no reported sinus infections and her symptoms were much
improved. She continues to use her topical nasal steroids.
Her asthma was much improved that her parents reported
discontinuation of all of her asthma medications.
9. Conclusions
CRS is a common disease in children which was shown
to have signiﬁcant impact on the quality of life of these
children. In the majority of cases medical treatment is very
successful; however, in a small percentage surgical treatment
mayneedtobeentertainedspeciﬁcallyinthosechildrenwith
asthma. Proper patient selection, counseling, and followup
are essential for a favorable surgical outcome.
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